ITK gene
Corvus Pharmaceuticals Reports Positive Phase 1 Data for Soquelitinib in Atopic Dermatitis, Exceeding Expectations
Corvus Pharmaceuticals; soquelitinib; Phase 1; atopic dermatitis; EASI reduction; ITK inhibitor
Actionable Insights Powered by AI
Corvus Pharmaceuticals; soquelitinib; Phase 1; atopic dermatitis; EASI reduction; ITK inhibitor